Why Bactiguard Holding stock moves
Bactiguard Holding fell, in line with the market.
Written after the close on ·
Why today
16,304 news analyzed todayBactiguard Holding fell, in line with the market.
Bactiguard Holding fell slightly in the last trading day, in line with OMX Stockholm 30, which fell clearly.
Over the last five trading days the stock fell slightly while the market was roughly flat.
That day it named its nomination committee for the 2027 annual general meeting, a routine governance step.
The move was an ordinary one for Bactiguard Holding, and no company news clearly explains it.
Today's move of −0.96% was 0.6 times a normal day's 1.7%. OMX Stockholm 30 moved −1.01% on the same day.
Bactiguard Holding −0.96%OMX Stockholm 30 −1.01%In step with the market
What analysts expect, and how often they have been right
Analysts’ estimates for Bactiguard Holding.
Bactiguard Holding earned more than expected in 7 out of 8 reports.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 3 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Price targets
Latest price 15.50 SEK
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedSEK
Next reported quarter: expected earnings per share of -0.10 SEK (February 4). For the current fiscal year, expected earnings per share changed from -0.43 SEK three months ago to -0.07 SEK now. 2026 estimate: -0.07 SEK. 2027 estimate: -0.14 SEK. One analyst made these estimates. People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor. August 27: Buy about 137 m SEK. February 25: Buy about 1.8 m SEK. December 17: Buy about 3.6 m SEK. November 18: Buy about 18 m SEK.
Has the share price followed the business?
Price and earnings moved in the same direction: 1 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed −44% and earnings per share went from -0.85 SEK to -0.22 SEK.
Revenue, profit and market cap
RevenueProfitMarket capHatched bars: analysts’ estimates.bn SEK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capbn SEK
Price and earnings moved in the same direction: 1 out of 3 years.Market cap (Now): 543 m SEKRevenue 2025: 216 m SEK
What the key figures say about Bactiguard Holding
The figures connect what Bactiguard Holding earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: -3.95 SEK–-0.22 SEK. Peers: Gentian Diagnostics -0.33 NOK, Microbot Medical -$0.25, C-Rad 1.41 SEK. 2026 estimate: -0.07 SEK (-0.07 SEK–-0.07 SEK). 2027 estimate: -0.14 SEK (-0.14 SEK–-0.14 SEK).
What the company sold during the year.
2022–2025: 204 m SEK–242 m SEK. Peers: Gentian Diagnostics 191 m NOK, Microbot Medical $0.3M, C-Rad 418 m SEK. 2026 estimate: 222 m SEK (222 m SEK–222 m SEK). 2027 estimate: 250 m SEK (250 m SEK–250 m SEK).
The percentage of revenue left after the costs of running the business.
2022–2025: −67.3%–−3.5%. Peers: Gentian Diagnostics −1.1%, Microbot Medical −5348.8%, C-Rad 13.1%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: −39.2%–−2.5%. Peers: Gentian Diagnostics −2.6%, Microbot Medical −32.9%, C-Rad 13.0%.
What investors pay for each unit the company sells.
2022–2025: 3.23–17.06. Peers: Gentian Diagnostics 3.16, Microbot Medical 215.47, C-Rad 1.89. 2026 estimate: 2.45. 2027 estimate: 2.17.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 2.86–4.44. Peers: Gentian Diagnostics -2.42, C-Rad -1.81.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 2.21–7.80. Peers: Gentian Diagnostics 3.17, Microbot Medical 1.08.
Cash left after investments, divided by the number of shares.
2022–2025: -1.74 SEK–0.29 SEK. Peers: Gentian Diagnostics 1.17 NOK, Microbot Medical -$0.27, C-Rad 0.39 SEK.
The percentage of assets financed by shareholders’ equity.
2022–2025: 50.1%–61.4%.
What followed similar falls?
Including reinvested dividends, Bactiguard Holding fell 3.1% over the latest five trading days. Since November 7, 2016, falls at least this large were followed by a higher value 21 trading days later in 47 out of 91 non-overlapping periods. The median was +0.3%, against +0.0% for an ordinary 21-day period, which ended higher 49 times in 100.
Such a fall has not said much about the next month.
+0.3% · 47/91
What to watch next, and why
The earnings report shows how Bactiguard Holding's revenue and profit have changed.
- Earnings report
The earnings report shows how Bactiguard Holding's revenue and profit have changed.
Add to calendar
More about Bactiguard Holding
Insider trades
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor.
- Thomas von Koch, chair (closely associated)Buyabout 137 m SEK
- Patrick Bach, CFO (closely associated)Buyabout 1.8 m SEK
- Patrick Bach, CFO (closely associated)Buyabout 3.6 m SEK
- Thomas von Koch, chair (closely associated)Buyabout 18 m SEK
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Bactiguard Holding usually moved about 4.7%. On a normal day it moves 1.7%.
+9.72% Why? +5.31% +1.42% +11.45%
10,000 SEK in Bactiguard Holding bought on November 7, 2016 is worth 10,400 SEK today, with dividends reinvested.
What would 10,000 SEK in Bactiguard Holding be worth today? →
What would 10,000 SEK in Bactiguard Holding be worth today?
10,400 SEK
with dividends reinvested, bought on November 7, 2016.
The five biggest days of the journey
· +30.6% · the whole market rose 1.0% the same day
· +24.9% · the whole market rose 0.3% the same day
· +24.2% · the whole market rose 1.1% the same day
· +23.8% · the whole market rose 0.9% the same day
· +21.9% · the whole market fell 0.4% the same day
Earlier days
−3.12% market −0.11% Bactiguard Holding fell slightly over the week while the broader market was roughly flat. Read →
Bactiguard Holding fell slightly over the week while the broader market was roughly flat.
The only company news was routine: a nomination committee was appointed on Friday 6 November to pick board members for the 2027 annual meeting.
That kind of notice rarely moves a share price much, so the small decline likely reflects ordinary day-to-day trading rather than a specific event.
The move was smaller than a normal day for the stock, and trading volume stayed around its usual level.
−4.35% market +0.83% Bactiguard Holding fell sharply, moving against the market. Read →
Bactiguard Holding fell sharply, moving against the market.
No company news from the last session explains the move.
Over the last five trading days, the shares fell clearly while OMX Stockholm 30 rose slightly.
Trading volume was far above normal, which suggests heavy selling pressure.
Earlier news from Monday last week reported results that beat expectations, so that is background rather than the cause.
+1.90% market −0.08% Bactiguard Holding rose, moving apart from the market. Read →
Bactiguard Holding rose, moving apart from the market.
No company news explains the move from that session.
Over the last five trading days it rose clearly, while OMX Stockholm 30 rose only slightly.
Likely drivers include the company's results beating expectations, which analysts had already started to reflect in their estimates.
Its next earnings report, the company's quarterly results, is due Thursday 4 February 2027.
−1.25% market +0.48% Bactiguard Holding fell slightly without a company-news explanation. Read →
Bactiguard Holding fell slightly without a company-news explanation.
Over the last five trading days the shares were roughly unchanged while OMX Stockholm 30 rose clearly.
The move was an ordinary one for Bactiguard Holding, and trading was well below its usual level.
Earlier news, including a shareholder reducing its stake, is background rather than a cause.
+3.23% market +3.01% Bactiguard Holding rose slightly over the week, moving in line with the broader Stockholm market, which rose clearly. Read →
Bactiguard Holding rose slightly over the week, moving in line with the broader Stockholm market, which rose clearly.
The main driver was the strong third-quarter report on 22 October: sales grew about 21% and the company returned to operating profit, a result that beat expectations.
Several analysts, including SEB and DNB Carnegie, published notes praising the results, which likely kept buyers interested after the report.
Trading in the shares was well below its usual level, and the latest day's move was ordinary.
+4.21% market +0.33% Bactiguard Holding rose sharply, without company news. Read →
Bactiguard Holding rose sharply, without company news.
Bactiguard rose sharply over the last five trading days, a very big move for the stock.
Over the same days, the OMX Stockholm 30 rose only slightly, so Bactiguard moved far more than the market.
The main driver was likely its third-quarter report, published last week, which showed net sales up about 21% and a return to operating profit.
Analysts also reacted positively, and the report beat expectations.
−3.73% market −3.67% Bactiguard Holding fell slightly over the last five trading days, moving in line with a sharply weaker OMX Stockholm 30. Read →
Bactiguard Holding fell slightly over the last five trading days, moving in line with a sharply weaker OMX Stockholm 30.
The main driver was the quarterly report, which showed revenue and profit growth and beat expectations.
Trading was far heavier than usual, and a large Handelsbanken Fonder stake sale was disclosed.
+9.72% market −2.51% Bactiguard Holding rose very sharply after its strong third-quarter report, while the market fell. Read →
Bactiguard Holding rose very sharply after its strong third-quarter report, while the market fell.
Over the last five trading days the shares were roughly unchanged, while OMX Stockholm 30 fell clearly, so the stock held up better than the market.
The rise in the last session came as the quarterly report beat expectations, with net sales up about 21 percent and adjusted operating profit (EBITDA, a measure of earnings before interest, tax and depreciation) turning clearly positive.
Trading volume was far above its usual level, a sign that many investors reacted to the report at once.
Learn more · Why do stocks go up and down?